Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease	Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy	Recruiting	Early phase 1	2026-01-07		NCT07323927

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Xuanwu Hospital, Beijing	232

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Xuanwu Hospital, Capital Medical University	Beijing	China	21

Clinical trials